Deep vein thrombosis future or investigational therapies

Jump to navigation Jump to search

Ongoing Research

Phase 3 Trials



Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism: Sponsored by Bristol-Myers Squibb and Pfizer<ref>http://clinicaltrials.gov/ct2/show/NCT00633893

  • Primary Outcome Measures: Venous Thromboembolic Recurrence or Death
  • Secondary Outcome Measures: Bleeding
  • Estimated Enrollment: 2,430 patients
  • Study Start Date: May 2008
  • Estimated Study Completion Date: August 2012
Retrieved from "https://www.wikidoc.org/index.php?title=Deep_vein_thrombosis_future_or_investigational_therapies&oldid=649543"